Application of sodium alginate microspheres in ischemic stroke modeling in miniature pigs

The miniature pig is an optimal animal model for studying nervous system disease because of its physiologic and pathologic features. However, the rete mirabile composed of arteries and veins at the skull base limits their application as a model of ischemic stroke by middle cerebral artery occlusion. The present study investigated the possibility of establishing an ischemic stroke model in the miniature pig by blocking the skull base retia with sodium alginate microspheres. Three Bama miniature pigs were used. Using the monitor of C-arm X-ray machine, sodium alginate microspheres (100-300 μm), a novel embolic material, were injected through the femoral artery, aortic arch, common carotid artery, ascending pharyngeal artery and the retia. Results were evaluated using carotid arteriography, MRI, behavior observation and histology. The unilateral rete mirabile was completely blocked, resulting in disturbance in blood supply to the basal ganglia, astasia of the right hind limb and salivation. MRI and hematoxylin-eosin staining showed an evident infarction focus in the basal ganglia. These findings indicate that sodium alginate microspheres are a suitable embolic material for blocking the skull base retia in miniature pigs to establish an ischemic stroke models.     

Repair of an articular cartilage defect using adipose-derived stem cells loaded on a polyelectrolyte complex scaffold based on poly(l-glutamic acid) and chitosan

As a synthetic polypeptide water-soluble poly(l-glutamic acid) (PLGA) was designed to fabricate scaffolds for cartilage tissue engineering. Chitosan (CHI) has been employed as a physical cross-linking component in the construction of scaffolds. PLGA/CHI scaffolds act as sponges with a swelling ratio of 760 ± 45% (mass%), showing promising biocompatibility and biodegradation. Autologous adipose-derived stem cells (ASCs) were expanded and seeded on PLGA/CHI scaffolds, ASC/scaffold constructs were then subjected to chondrogenic induction in vitro for 2 weeks. The results showed that PLGA/CHI scaffolds could effectively support ASC adherence, proliferation and chondrogenic differentiation. The ASCs/scaffold constructs were then transplanted to repair full thickness articular cartilage defects (4 mm in diameter, to the depth of subchondral bone) created in rabbit femur trochlea. Histological observations found that articular defects were covered with newly formed cartilage 6 weeks post-implantation. After 12 weeks the regenerated cartilage had integrated well with the surrounding native cartilage and subchondral bone. Toluidine blue and immunohistochemical staining confirmed similar accumulation of glycosaminoglycans and type II collagen in engineered cartilage as in native cartilage 12 weeks post-implantation. The result was further supported by quantitative analysis of extracellular matrix deposition. The compressive modulus of the engineered cartilage increased significantly from 30% of that of normal cartilage at 6 weeks to 83% at 12 weeks. Cyto-nanoindentation also showed analogous biomechanical behavior of the engineered cartilage to that of native cartilage. The results of the present study thus demonstrate the potentiality of PLGA/CHI scaffolds in cartilage tissue engineering.     

Systematic screen with kinases inhibitors reveals kinases play distinct roles in growth of osteoprogenitor cells

Cancer treatment-related bone loss has become growing problematic, especially in breast and prostate cancer treated with hormone/endocrine therapy, chemotherapy and radiotherapy. However, bone loss caused by targeted therapy in cancer patients is largely unknown yet. In present study, a kinase inhibitors screen was applied for MC3T3-E1, a murine osteoprogenitor cell line, and seven kinase inhibitors (GSK1838705A, PF-04691502, Dasatinib, Masitinib, GDC-0941, XL880 and Everolimus) were found to suppress the cell viability with dose- and time-dependent manner. The most interesting is that many kinase inhibitors (such as lapatinib, erlotinib and sunitinib) can promote MC3T3-E1 cell proliferation at 0.01 μM. 4 out of 7 inhibitors were selected to perform the functional study and found that they lead to cell cycle dysregulation, treatments of PF-04691502 (AKT inhibitor), Dasatinib (Src inhibitor) and Everolimus (mTOR inhibitor) lead to G1 arrest of MC3T3-E1 cells via downregulation of cyclin D1 and p-AKT, whereas XL880 (MET and VEGFR inhibitor) treatment results in increase of sub-G1 and G2/M phase by upregulation of p53 protein. Our work provides important indications for the comprehensive care of cancer patients treated with some targeted drugs.     

Serologic Evidence of Pandemic Influenza Virus H1N1 2009 Infection in Cats in China

Infection of domestic cats with (H1N1) pandemic 2009 (pdm09) influenza A virus has recently been documented. In this paper, we report for the first time the sporadically current seroprevalence of (H1N1) pdm09 influenza A virus infection in cats in China. Thirteen of 1,080 sera were found positive by nucleoprotein (NP)-specific enzyme-linked immunosorbent assays (ELISAs) in different cat populations in southern China. It is very important to stress further surveillance of pandemic (H1N1) 2009 influenza A virus in cats in southern China.     

奇静脉的临床应用解剖

目的 观测奇静脉的解剖学结构,丰富奇静脉临床应用形态学数据.方法 解剖30具经福尔马林固定的尸体标本,观测奇静脉的起始、走行、外形、属支、管径、与胸导管位置关系.结果 奇静脉的位置与走行可分为三种类型.奇静脉主干长度与管径值:长度(18.45 ±2.95) cm,起端管径(0.46 ±0.12) cm,中段管径为(0.90 ±0.20) cm,末端管径为(1.24±.0.30) cm.中段凸向前正中线左侧16例,占53.33％,凸出度均值0.53 cm.半奇静脉与副半奇静脉、奇静脉与胸导管的位置关系等较为复杂.结论 奇静脉起始部位、长度、管径、位置走行差异较大,整体走行与属支存在多种类型,与胸导管的位置关系多变,临床上应予以充分注意.     

Do Implant Length and Width Matter for Short Dental Implants (<10 mm)? A Meta‐Analysis of Prospective Studies

Background: This meta‐analysis of prospective clinical trials was conducted to determine the effects of dental implant length and width on implant survival rate of short (<10 mm) implants. Methods: An electronic search of the PubMed database for relevant studies published in English from November 1998 to March 2012 was performed. Selected studies were randomized clinical trials, human clinical trials, or prospective trials with a clear aim of investigating the success or survival rate of short (<10 mm) implants. Results: Eight studies fulfilled the inclusion criteria and were subsequently analyzed. A total of 525 short (<10 mm) dental implants were analyzed, of which 253 were 3.5 mm in diameter (48.19%), 151 were 4.0 mm (28.76%), 90 were 4.1 mm (17.14%), 21 were 4.8 mm (4%), and 10 were 5.1 mm (1.9%). All implants included in this meta‐analysis had a follow‐up period of 12 to 72 months. The included studies reported on the survival rate and diameter of the implants. Six of the studies used “short implants” (7 to 9 mm), and the remaining were classified as “extra‐short implants” (≤6 mm). Five‐year estimated failure rates were 1.61% and 2.92%, respectively, for extra‐short and short implants (z = ?3.49, P <0.001, 95% confidence interval = 0.51% to 4.10%). Furthermore, it was found that the wider the implant, the higher the failure rate (estimated failure rate = 2.36%, 95% confidence interval = 1.07% to 5.23%). Conclusions: Neither implant length nor width seemed to significantly affect the survival rate of short implants (<10 mm). Nonetheless, further well‐designed randomized clinical trials are needed to confirm these findings.     

构建一种新型牙周膜牙囊复合细胞膜片的研究

目的：拟构建一种牙周膜牙囊复合细胞膜片,并比较其与单一膜片的性能差异,以期寻找一种更加优越的牙周缺损修复材料。方法：将第三代牙周膜干细胞及牙囊干细胞直接混合共同培养,将牙周膜牙囊混合细胞、牙周膜干细胞及牙囊干细胞分别制备成细胞膜片,应用HE染色,扫描电镜比较三种膜片形态学差异,应用茜素红染色,RT—PCR比较三种膜片成骨能力差异。结果：扫描电镜结果显示,牙囊牙周膜混合细胞膜片分泌更多的细胞外基质。HE染色结果也显示牙囊牙周膜混合细胞膜片细胞层数更多,基质分泌量更大。同时,牙囊牙周膜混合细胞膜片AIJP、Runx2、OCN表达显著高于单一细胞膜片。成骨诱导21天后,茜素红染色结果显示,与单一细胞膜片相比,牙囊牙周膜混合细胞膜片染色更深。结论：牙周膜牙囊复合细胞膜片较单一细胞膜片,细胞层数更多,基质分泌量更大,骨向分化能力更强,为牙周再生提供了新的思路。     

牙周内窥镜下刮治与传统刮治对龈下牙石清除效果的比较

目的比较内窥镜下龈下刮治与传统龈下刮治清除龈下牙石的效果。方法收集16例患者26颗无保留价值的重度慢性牙周炎患牙,随机分为两组,每组8例13颗患牙,分别行牙周内窥镜下龈下刮治(A组)及传统龈下刮治(B组),每颗患牙均刮治10min后拔除,亚甲基蓝染色后,蓝色显示残留牙石,对每颗牙颊、舌、近中及远中面拍照并用Image Pro Plus图像分析软件检测、计算各牙面的牙石残留率。比较两组患牙治疗后的牙石残留率以及吸烟、牙周探诊出血位点数和牙周探诊深度对牙石清除效果的影响。结果 A组患牙平均牙石残留率为(8.34±1.70)%,B组患牙平均牙石残留率为(13.02±3.36)%,差异有统计学意义(P<0.05)。吸烟、探诊出血位点数、牙周探诊深度对治疗后的牙石残留率均有影响(P<0.05)。结论在牙周内窥镜下行龈下刮治,清除牙石的效果明显优于传统龈下刮治。吸烟、探诊出血、探诊深度对牙石残留率均有影响。